Raymond James & Associates G1 Therapeutics, Inc. Put Options Transaction History
Raymond James & Associates
- $146 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GTHX
# of Institutions
95Shares Held
14.7MCall Options Held
631KPut Options Held
347K-
Vanguard Group Inc Valley Forge, PA2.08MShares$5.1 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA951KShares$2.33 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny904KShares$2.21 Million0.01% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY785KShares$1.92 Million0.0% of portfolio
-
Black Rock Inc. New York, NY672KShares$1.65 Million0.0% of portfolio
About G1 Therapeutics, Inc.
- Ticker GTHX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,746,800
- Market Cap $105M
- Description
- G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...